A humanized system for pharmacologic control of gene expression.
about
Forkhead/winged-helix transcription factor Whn regulates hair keratin gene expression: molecular analysis of the nude skin phenotypeEpithelial and ectomesenchymal role of the type I TGF-beta receptor ALK5 during facial morphogenesis and palatal fusionRabGEFs are a major determinant for specific Rab membrane targetingRapid and orthogonal logic gating with a gibberellin-induced dimerization systemBicaudal D induces selective dynein-mediated microtubule minus end-directed transportA functional screen in human cells identifies UBF2 as an RNA polymerase II transcription factor that enhances the beta-catenin signaling pathwayInhibition of established collagen-induced arthritis with a tumour necrosis factor-alpha inhibitor expressed from a self-contained doxycycline regulated plasmidA gene expression system offering multiple levels of regulation: the Dual Drug Control (DDC) systemA novel mammalian expression system derived from components coordinating nicotine degradation in arthrobacter nicotinovorans pAO1.Structure and function of outer dynein arm intermediate and light chain complex.A ligand-reversible dimerization system for controlling protein-protein interactionsRedesigning an FKBP-ligand interface to generate chemical dimerizers with novel specificityBuilding synthetic cellular organizationTransgene regulation using the tetracycline-inducible TetR-KRAB system after AAV-mediated gene transfer in rodents and nonhuman primatesControlled dimerization of ErbB receptors provides evidence for differential signaling by homo- and heterodimersCompartmental signal modulation: Endosomal phosphatidylinositol 3-phosphate controls endosome morphology and selective cargo sorting.Regulation of retinal function but nonrescue of vision in RPE65-deficient dogs treated with doxycycline-regulatable AAV vectorsSynthetic spatially graded Rac activation drives cell polarization and movement.Activation of NF-κB signalling by fusicoccin-induced dimerization.Identification of inhibitors of ribozyme self-cleavage in mammalian cells via high-throughput screening of chemical libraries.The cumate gene-switch: a system for regulated expression in mammalian cells.A time- and dose-dependent STAT1 expression system.Adeno-associated viral vectors engineered for macrolide-adjustable transgene expression in mammalian cells and miceConditional transgenesis using Dimerizable Cre (DiCre)Vector and helper genome rearrangements occur during production of helper-dependent adenoviral vectors.A yeast genetic system for selecting small molecule inhibitors of protein-protein interactions in nanodroplets.A nonnatural transcriptional coactivatorMidbrain injection of recombinant adeno-associated virus encoding rat glial cell line-derived neurotrophic factor protects nigral neurons in a progressive 6-hydroxydopamine-induced degeneration model of Parkinson's disease in rats.Promoter-activated expression of nerve growth factor for treatment of neurodegenerative diseases.Evaluation of a rapamycin-regulated serotype 2 adeno-associated viral vector in macaque parotid glandsRegulated gene expression systems.Light-inducible gene regulation with engineered zinc finger proteinsRegulatable systems: applications in gene therapy and replicating viruses.Advances in neurofibromatosis 2 (NF2): a workshop report.Recruitment of Mad1 to metaphase kinetochores is sufficient to reactivate the mitotic checkpoint.Conditional targeting of MAD1 to kinetochores is sufficient to reactivate the spindle assembly checkpoint in metaphase.Advances in skin gene therapy.Design and Applications of Bifunctional Small Molecules: Why Two Heads Are Better Than One.Cancer gene therapy: developments to 2000.Gene therapy in wound repair and regeneration.
P2860
Q22253904-441A5255-E17C-4CF2-8D5A-53246B0631D6Q24294844-08AFE509-FC45-401B-96BC-09A6AE912DFCQ24314408-0F691A62-E0C7-4550-BA4C-5C10F6B8B95EQ24609546-0801DBEF-0EDE-4A0D-8613-196B89719970Q24644322-13651AFC-A25E-465A-90AF-017E9FBD587AQ24673336-5983A241-5EBD-494C-B0C7-52D16FB5EA36Q24793412-2E69C076-C614-48BE-88A2-9E7F9584790DQ24806707-E0377E22-3A99-4E98-8BD1-CDDF2CB56DF5Q24816289-4C9F69D5-0868-4BCD-AD13-EA8319809863Q27304940-CB5AA1C8-7A5A-4CAA-A7DE-C81BE78FDB2DQ27624913-1453D7B3-9896-4737-B8AE-5B5571BB9997Q27765263-314FF421-42C8-4EE2-B904-136F7EC9A6D9Q28302982-26E9C3B8-4862-4E56-9237-6E0B08301FD6Q28543150-801FD854-9058-4FE7-9F4A-9A54A704AEBEQ28679173-B386372E-617F-477A-A9AB-2160D4B172B1Q30478189-327220FA-4F2E-4054-BB2E-9ECB30D259A5Q30495021-8ACDF619-592D-443C-B7A3-D7A708ECC3EAQ30531107-882D4AAB-CBF1-41CD-A602-CF34139E7E42Q30533996-891549C8-1A06-4F09-B20E-EC8BE96E8FF2Q33237400-695ACFFC-F2FE-4597-9D55-7EB2D94C24A6Q33262655-7750E482-C2F3-4FCE-8069-C6761A965ADFQ33267385-2D47AEB6-2825-455C-BD7C-B54780A7BA9CQ33305143-3D12519B-6C2B-4BE9-866F-5C1E664F4534Q33312374-CEE79B9E-20DB-44DD-B0BA-96033B94C9B3Q33586303-E225FEAD-2B52-497A-9BB1-F08C566ACD57Q33701077-F563BEBC-16C1-4A00-8BF8-C31DE649C93AQ33701286-AA6731D2-2605-4CDD-BDAC-1D51A1A95748Q33745707-02568A73-D3B3-4CF4-AF2B-05795CE1C56BQ33749480-63EE7611-DE64-4130-BD3C-00DBD6074D1DQ33782319-CED02D5F-CBF3-4FE0-8EC4-C6D3A49CF8F2Q33837136-30A96ED9-21A1-4DFC-8DAB-A856A321B0DCQ33849650-BA6F5DBA-C578-4CB1-A4E1-917FA76212DCQ33904282-8E304BF3-6758-497F-9201-24C6ED3FC84BQ34035897-21B7AA71-5A50-45D5-B94F-DE42443E9097Q34040203-2ACFEAD5-835D-4984-8AF6-96328DD98EA3Q34040427-72B181CF-46DD-4D19-9E17-3D02599BD1FAQ34075060-F7BE5989-3F18-491F-8921-4163078DA312Q34077604-2D9C1C51-9F09-4569-A623-06FB6D161B79Q34090963-9114F47C-DAFB-452D-8BBA-E44852A30B4BQ34156741-29AA56B2-890A-4DDF-9390-A856455CA5B8
P2860
A humanized system for pharmacologic control of gene expression.
description
1996 nî lūn-bûn
@nan
1996 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
1996 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
1996年の論文
@ja
1996年論文
@yue
1996年論文
@zh-hant
1996年論文
@zh-hk
1996年論文
@zh-mo
1996年論文
@zh-tw
1996年论文
@wuu
name
A humanized system for pharmacologic control of gene expression.
@ast
A humanized system for pharmacologic control of gene expression.
@en
A humanized system for pharmacologic control of gene expression.
@nl
type
label
A humanized system for pharmacologic control of gene expression.
@ast
A humanized system for pharmacologic control of gene expression.
@en
A humanized system for pharmacologic control of gene expression.
@nl
prefLabel
A humanized system for pharmacologic control of gene expression.
@ast
A humanized system for pharmacologic control of gene expression.
@en
A humanized system for pharmacologic control of gene expression.
@nl
P2093
P2860
P356
P1433
P1476
A humanized system for pharmacologic control of gene expression.
@en
P2093
Cerasoli F Jr
Clackson T
Courage NL
Phillips T
P2860
P2888
P304
P356
10.1038/NM0996-1028
P407
P577
1996-09-01T00:00:00Z